Neurotrophic Effect of Citrus 5-Hydroxy-3,6,7,8,3′,4′-Hexamethoxyflavone: Promotion of Neurite Outgrowth via cAMP/PKA/CREB Pathway in PC12 Cells by Lai, Hui-Chi et al.
Neurotrophic Effect of Citrus 5-Hydroxy-3,6,7,8,39,49-
Hexamethoxyflavone: Promotion of Neurite Outgrowth
via cAMP/PKA/CREB Pathway in PC12 Cells
Hui-Chi Lai
1, Ming-Jiuan Wu
2, Pei-Yi Chen
3,4, Ting-Ting Sheu
5, Szu-Ping Chiu
1, Meng-Han Lin
2, Chi-Tang
Ho
6, Jui-Hung Yen
1,3*
1Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien, Taiwan, 2Department of Biotechnology, Chia-Nan University of Pharmacy and
Science, Tainan, Taiwan, 3Institute of Medical Science, Tzu Chi University, Hualien, Taiwan, 4Center of Medical Genetics, Buddhist Tzu Chi General Hospital, Hualien,
Taiwan, 5Institute of Microbiology, Immunology and Biochemistry, Tzu Chi University, Hualien, Taiwan, 6Department of Food Science, Rutgers University, New Brunswick,
New Jersey, United States of America
Abstract
5-Hydroxy-3,6,7,8,39,49-hexamethoxyflavone (5-OH-HxMF), a hydroxylated polymethoxyflavone, is found exclusively in the
Citrus genus, particularly in the peels of sweet orange. In this research, we report the first investigation of the neurotrophic
effects and mechanism of 5-OH-HxMF in PC12 pheochromocytoma cells. We found that 5-OH-HxMF can effectively induce
PC12 neurite outgrowth accompanied with the expression of neuronal differentiation marker protein growth-associated
protein-43(GAP-43). 5-OH-HxMF caused the enhancement of cyclic AMP response element binding protein (CREB)
phosphorylation, c-fos gene expression and CRE-mediated transcription, which was inhibited by 2-naphthol AS-E phosphate
(KG-501), a specific antagonist for the CREB-CBP complex formation. Moreover, 5-OH-HxMF-induced both CRE transcription
activity and neurite outgrowth were inhibited by adenylate cyclase and protein kinase A (PKA) inhibitor, but not MEK1/2,
protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K) or calcium/calmodulin-dependent protein kinase (CaMK)
inhibitor. Consistently, 5-OH-HxMF treatment increased the intracellular cAMP level and downstream component, PKA
activity. We also found that addition of K252a, a TrKA antagonist, significantly inhibited NGF- but not 5-OH-HxMF-induced
neurite outgrowth. These results reveal for the first time that 5-OH-HxMF is an effective neurotrophic agent and its effect is
mainly through a cAMP/PKA-dependent, but TrKA-independent, signaling pathway coupling with CRE-mediated gene
transcription. A PKC-dependent and CREB-independent pathway was also involved in its neurotrophic action.
Citation: Lai H-C, Wu M-J, Chen P-Y, Sheu T-T, Chiu S-P, et al. (2011) Neurotrophic Effect of Citrus 5-Hydroxy-3,6,7,8,39,49-Hexamethoxyflavone: Promotion of
Neurite Outgrowth via cAMP/PKA/CREB Pathway in PC12 Cells. PLoS ONE 6(11): e28280. doi:10.1371/journal.pone.0028280
Editor: Charleen T. Chu, University of Pittsburgh, United States of America
Received June 27, 2011; Accepted November 4, 2011; Published November 29, 2011
Copyright:  2011 Lai, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grant NSC-97-2320-B-320-011-MY3 and NSC-99-2320-B-041-005 -MY3 from National Science Council, Taiwan, Republic of
China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: imyenjh@mail.tcu.edu.tw
Introduction
Neurotrophic factors, such as nerve growth factor (NGF) and
brain-derived neurotrophic factor (BDNF) have been reported to
promote neurogenesis, neural development, neuronal survival and
functional maintenance of neurons [1,2]. The levels of neurotrophic
factors are changed in a wide variety of neurodegenerative
disorders, such as Alzheimer’s disease (AD), Parkinson’s disease,
Huntington’s disease and amyotrophic lateral sclerosis [3]. NGF is
known as the most efficacious neurotrophic factor acting on the
basal forebrain cholinergic neurons (BFCNs) and suggested as a
potential therapeutic agent for degeneration of cholinergic neurons
inpatientswith AD[2].However,NGFisa large sizeofpolypeptide
and its supplementation on the peripheral administration is severely
restricted by the difficulties in the blood-brain-barrier (BBB)
penetration [4]. In addition, NGF has been reported to interact at
low affinity with p75 receptor and lead to undesirable effects such as
pain[5].Asa result,identificationofsmallmoleculesthatcanmimic
the neuritogenic ability of NGF and substitute for its clinical use
serves as an alternative therapy approach [6].
PC12 pheochromocytoma cell line is a widely used model
system for studies of neuronal cell differentiation, neuronal
survival, and neurotransmitter secretion, as well as defining the
underlying molecular mechanisms [7]. Exposure of PC12 cells to
NGF triggers differentiation into sympathetic-like neuronal cells,
characterized by long-term and stable neurite outgrowth and
exhibiting many properties of adrenal medullary chromaffin cells,
including catecholamine synthesis, storage, and secretion [8]. NGF
induces rapid tyrosine phosphorylation of trkA and consequent
phosphorylation and activation of signal transduction substrates
including extracellular signal regulated kinases (ERKs)/mitogen-
activated protein kinases (MAPKs) [9,10]. It has been reported
that NGF-mediated ERK activation induces phosphorylation of
cAMP-response element binding protein (CREB), which further
recruits the CREB binding protein (CBP) to the promoter regions
of cAMP-responsive genes associated with dendritic spine growth,
morphology change, synaptic plasticity, and long-term memory
[11,12]. In addition to ERK/MAPK, various individual signaling
cascades may converge signal to the CREB, including protein
kinase C (PKC) [13], cAMP-dependent protein kinase A (PKA)
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28280[14,15], phosphatidylinositol 3-kinase (PI3K)/Akt [16,17], and
calcium/calmodulin-dependent protein kinase (CaMK) [18,19].
It is known that several phytochemicals derived from daily
consumed vegetables and fruits are associated with disease-
preventing effects. Flavonoids, a family of polyphenolic phyto-
chemicals, have been shown to alter cell signaling and gene
expression which might contribute to their purported physiological
benefits [20,21]. Polymethoxyflavones (PMFs) exist almost exclu-
sively in the peels of citrus such as sweet orange (Citrus sinensis (L.)
Osbeck) and mandarin orange (Citrus reticulate Blanco). The roles of
PMFs in prevention and treatment of diseases have received
considerable attention recently, with particular interest in the use
of these citrus flavonoids as antioxidant, anti-inflammatory, anti-
cancer, and anti-atherogenic agents [22–26]. Nobiletin (Figure 1),
the most abundant and studied PMF in orange peel extract [23],
has been found to induce neurite outgrowth through cAMP and
ERK/MAPK-dependent mechanism [27], to stimulate CRE
transcription activity [28], to enhance long-term potentiation
(LTP) in the hippocampal slices [29], and to improve impaired
memory in animal models including olfactory-bulbectomized,
Alzheimer’s disease, and brain-ischemia mice [30–32]. A metab-
olite of nobiletin, 49-demethylnobiletin, has also been reported to
rescue learning impairment via stimulation of ERK and CREB
signaling pathways [33]. The recent isolation of 5-hydroxy-3,6,7,8,
39,49-hexamethoxyflavone (5-OH-HxMF) (Figure 1), a 5-hydrox-
ylated PMF, from sweet orange peel extract [23] and the reported
biological activities of relevant polymethoxyflavones mentioned
above promoted us to study its neurotrophic and neuroprotective
activities. In the present study, we focused on the neurotrophic
effect of 5-OH-HxMF on promoting neurite outgrowth and
neuronal differentiation in PC12 cells. We also explored the
possible signaling molecular pathways associated with its neuro-
trophic action. It is noteworthy that this is the first report on the
neurotrophic action and mechanism of 5-hydroxylated PMFs.
Results
5-OH-HxMF promotes PC12 neurite outgrowth
PC12 cell line is widely used as a cellular model for studies of
neurotrophic action [8]. To evaluate the effect of the 5-
hydroxylated polymethoxyflavone on cell viability in PC12 cell
system, cells were maintained in the low serum medium (1% HS
and 0.5% FBS) and treated with indicated concentration of vehicle
(0.1% DMSO), NGF (50 ng/ml=0.38 nM; as a positive control),
5-OH-HxMF or nobiletin (0–50 mM) for 48 h. The relative cell
counts were analyzed using MTT assay and values were expressed
as percentage of control group. As shown in Figure S1, NGF
exerted a proliferative effect in PC12 cells in low serum culture
condition. The 5-OH-HxMF and nobiletin showed no further
decrease in viability and sustained PC12 cell survival in low serum
medium. This result reveals none of these two PMF compounds
exhibited cytotoxicity for 48 h incubation in this low serum culture
system. To evaluate the neuritogenic action in our cell system,
adherent PC12 cells in low serum medium (1% HS and 0.5% FBS)
were treated with neurotrophic factor NGF (25–100 ng/
ml=0.19–0.76 nM) for quantification of neurite outgrowth. Cell
morphology was observed and percentage of neurite-bearing cells
was counted by phase contrast microscopy. Figure S2 shows that
NGF significantly promoted neurite outgrowth of low-serum
cultured PC12 cells in a dose- and time-dependent manner.
Growth-associated protein-43 (GAP-43) is a neuron-specific
protein which exhibits increased synthesis and axonal fast-
transport during nerve regeneration. The correlation of elevated
GAP-43 expression with neuronal growth states is well established
[34,35]. To confirm our morphological observation at the
molecular level, we immunostained for GAP-43 expression after
NGF (100 ng/ml=0.76 nM) treatment for 48 h. NGF-differenti-
ated PC12 cells displayed extensive expression of the neuronal
differentiation marker GAP-43 (Figure S2C).
To investigate whether citrus polymethoxyflavones also induce
neurite outgrowth in PC12 cells, adherent cells maintained in low
serum medium were treated with vehicle (0.1% DMSO), 5-OH-
HxMF, or nobiletin (5, 10, and 20 mM) for 48 h for analysis of cell
morphology change (Figure 2A). As shown in Figure 2B,
quantification of neurite outgrowth data showed that treatment of
PC12 cells with 5-OH-HxMF and nobiletin significantly evoked a
dose-dependent increase on neurite outgrowth and the percentage
of neurite-bearing cells markedly reached 24.463.0%,
32.862.7%, and 37.360.3% for 5 mM, 10 mM, and 20 mM5 -
OH-HxMF; 16.861.2%, 24.062.7% and 32.963.8% for 5 mM,
10 mM, and 20 mM nobiletin, respectively (p,0.01). 5-OH-HxMF
and nobiletin also significantly increased the maximal neurite
length in those cells (24.461.7 mm, 25.761.8 mm, and
34.362.8 mm for 5 mM, 10 mM, and 20 mM 5-OH-HxMF;
20.362.8 mm, 27.463.6 mm, and 38.563.0 mm for 5 mM,
10 mM, and 20 mM nobiletin, respectively) as compared with
those of the vehicle control (11.961.2 mm) (p,0.01). These above
results indicate that 5-OH-HxMF and nobiletin possess compat-
ible neurotrophic activity as NGF.
5-OH-HxMF promotes GAP-43 expression in PC12 cells
To further confirm the neurotrophic effect of 5-OH-HxMF,
GAP-43 expression was determined by Western blot analysis and
RT-Q-PCR. Figure 3A shows NGF (50 ng/ml=0.38 nM)
significantly increased GAP-43 mRNA expression (approximately
2.5-fold) over vehicle control (p,0.01). Cells treated with 10 and
20 mM 5-OH-HxMF for 24 h caused 1.4- and 2.0-fold increases in
the GAP-43 transcripts, respectively. Western blot analysis reveals
GAP-43 protein expression was significantly induced by 5-OH-
HxMF after 24 h of treatment. GAP-43 protein levels were
elevated 1.5-, 1.3-, and 2.1-fold in response to NGF (50 ng/
mL=0.38 nM), 10 and 20 mM 5-OH-HxMF, respectively
(Figure 3B). These results reveal that 5-OH-HxMF induces the
Figure 1. Chemical structure of 5-Hydroxy-3,6,7,8,39,49-hexam-
ethoxyflavone (5-OH-HxMF) and nobiletin.
doi:10.1371/journal.pone.0028280.g001
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e28280Figure 2. Morphological characteristics of 5-OH-HxMF- and nobiletin-treated PC12 cells. PC12 cells were seeded on poly-L-lysine-coated
6-well plates in low serum medium for 24 h prior to exposure to vehicle (0.1% DMSO) or indicated agents for additional 48 h. Cell morphology was
observed using phase-contrast microscopy and photographed by the digital camera. Arrowheads indicate the neurite bearing cells in 5-OH-HxMF- or
nobiletin-treated groups. Scale bar, 100 mm. (B) Neurite bearing cells were analyzed as described in Materials and Methods. Data represent the mean
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e28280mRNA and protein expression of GAP-43 associated with the
differentiation of PC12 cells into neuronal phenotype.
5-OH-HxMF stimulates phosphorylation of CREB in PC12
cells
Several reports suggested that phosphorylation of transcription
factor CREB played critical roles for neurogenesis and neuronal
differentiation [36–38]. To investigate whether 5-OH-HxMF can
activate CREB signaling, PC12 cells were treated with 20 mM5 -
OH-HxMF and nobiletin for indicated period, and cell lysate was
immunoblotted with phospho-CREB (p-CREB) and CREB
specific antibodies as described in Materials and Methods. As
shown in Figure 4, treatment of PC12 cells with 20 mM 5-OH-
HxMF increased CREB phosphorylation by 1.5-fold within
30 min, peaked by 60 min (2-fold), and lasted until 120 min
(1.3-fold) as compared with 0 min group (p,0.01). In comparison,
CREB phosphorylation peaked at 60 min by nobiletin and then
rapidly decreased. This data shows that 5-OH-HxMF and
nobiletin activate rapid and transient CREB phosphorylation in
PC12 cells.
Effects of 5-OH-HxMF-induced CREB phosphorylation on
the CRE-dependent transcription activity and neurite
outgrowth in PC12 cells
To determine whether 5-OH-HxMF-induced CREB phosphor-
ylation can also activate the transcription activity of cAMP response
element (CRE), the CRE-mediated luciferase reporter plasmid and
Renilla internal control vector were co-transfected into the PC12
cells, then the luciferase activity was measured as described in
MaterialsandMethods.AsshowninFigure5A,treatmentofPC12
cells with 20 mM 5-OH-HxMF and nobiletin increased the
luciferase activity by approximately 6.5-fold compared to vehicle
control (p,0.01), respectively. The 5-OH-HxMF or nobiletin-
mediated transcription activity was significantly reduced by
treatment of cells with 10 mM 2-naphthol AS-E phosphate (KG-
501), a specific antagonist which disrupts the CREB:CBP complex
and attenuates target gene induction [39]. This result reveals that 5-
OH-HxMF can induce transcription of CRE-dependent genes. In
addition, we further determined the effect of 5-OH-HxMF on the
CREB target gene, c-fos, in PC12 cells. As shown in Figure 5B,
exposure of PC12 cells with 5-OH-HxMF (20 mM) increased c-fos
mRNA expression within 30 min and peaked by 120 min. This
result confirms 5-OH-HxMF can activate CREB, which in turn up-
regulates downstream target gene- c-fos.
As shown in Figure 5C, KG-501 treatment for 48 h in culture
medium also significantly attenuated the percentage of 5-OH-
HxMF and nobiletin-induced neurite-bearing cells from
34.462.3% to 12.762.1% and 32.963.7% to 8.161.4%, respec-
tively (p,0.01). The average maximal neurite length in those
differentiated cells was also reduced to the vehicle control level
(Figure 5D). These results imply that both 5-OH-HxMF and
nobiletin upregulate neurite outgrowth through CREB activation.
5-OH-HxMF promotes CREB activation and neurite
outgrowth through cAMP-dependent PKA signaling
pathway in PC12 cells
Many data supported that CREB transcriptional regulation
represents a crossing point for several signaling pathways and is
known to regulate a variety of genes in neuronal functions [40–
42]. To unravel the enigma, the possible involvement of ERK,
PKC, PI3K/Akt, CaMK and cAMP-dependent PKA signaling in
5-OH-HxMF-upregulated CREB transcription activation was
investigated by utilizing their molecular inhibitors. PC12 cells
were transfected with reporter plasmids and treated with kinases
specific inhibitors including MEK1/2 inhibitor (U0126; 10 mM),
PKC inhibitor (bisindolylmaleimide I, BIM; 2.5 mM), PI3K
inhibitor (LY294002; 20 mM), CaMK II inhibitor (KN-62;
10 mM), adenylate cyclase inhibitor (SQ22536; 500 mM) and
PKA inhibitor (H-89; 10 mM) for 30 min, then incubated with
20 mM 5-OH-HxMF before analyzing the luciferase activity of
cells. As shown in Figure 6A, 5-OH-HxMF as well as forskolin,
an adenylate cyclase activator for CREB-mediated transcriptional
activation, significantly increased the CRE-dependent transcrip-
tion, as expected. Moreover, 5-OH-HxMF-mediated CREB-
transcription activity was markedly attenuated by SQ22536 and
H-89 to the vehicle control level (p,0.01). As shown in Figure 6B,
immunoblot shows that SQ22536 and H-89 treatment of PC12
cells specifically abolished 5-OH-HxMF-mediated CREB phos-
phorylation by 32% and 60%, respectively (p,0.01), without
changing those of vehicle control.
The effect of 5-OH-HxMF on intracellular cAMP levels was
further measured using the Enzyme Immunoassay kit as described
in Materials and Methods. Figure 7A shows that intracellular
cAMP levels peaked at 15 min treatment and then slightly
decreased until 60 min (p,0.01). Moreover, we analyzed the
effect of 5-OH-HxMF on the protein kinase A activity using the
ELISA-based PKA activity assay kit as described in Materials and
Methods and found similar kinetics with peak at 15 min (p,0.01)
and then fell off (p,0.05) (Figure 7B). These results indicate the
possible involvement of cAMP-dependent PKA signaling pathway
in 5-OH-HxMF-mediated CREB activation. The cAMP produc-
tion and PKA activity may play an essential role for channeling 5-
OH-HxMF signaling to CREB activation in PC12 cells.
To determine the role of cAMP-dependent PKA signaling
pathway on 5-OH-HxMF-induced neurite outgrowth, we treated
cells with 5-OH-HxMF in the presence of specific inhibitors. As
shown in Figure 7C, exposure of cells to SQ22536 and H-89
significantly attenuated the percentage of neurite-bearing cells
from the original 37.360.3% to 12.662.0% and 20.660.9%,
respectively (p,0.01). The maximal neurite length in those
neurite-bearing cells also reduced from the original
37.362.8 mm to 23.862.3 mm and 21.361.8 mm, respectively
(p,0.01). These results further confirm the vital role of cAMP/
PKA/CREB pathway in 5-OH-HxMF-induced neurite outgrowth
in PC12 cells. However, the inhibitory potencies of these two
inhibitors, especially H-89, on 5-OH-HxMF-induced neurite
outgrowth are weaker than that of KG-501 (Figure 5), indicating
there remains an unidentified CREB upstream signaling.
5-OH-HxMF promotes neurite outgrowth in PC12 cells is
not via TrkA-mediated actions
It is known that NGF could act on tyrosine kinase receptor A
(TrkA) and regulate neuronal differentiation through CREB by
causing an elevation of the cAMP, which activates protein kinase
A [43]. To evaluate whether 5-OH-HxMF serves as a small-
molecular agonist for TrkA, PC12 cells were treated with 20 mM
5-OH-HxMF or 100 ng/ml NGF (as a control) alone or in
6 SD from three independent experiments. The maximal neurite length for each of the differentiated cells was analyzed and the average neurite
length was calculated as described in Materials and Methods. Data represent the mean 6 SD from three independent experiments. **p,0.01
represents significant differences compared with those of the vehicle-treated cells.
doi:10.1371/journal.pone.0028280.g002
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e28280Figure 3. Effects of 5-OH-HxMF on GAP-43 mRNA and protein expression in PC12 cells. PC12 cells were seeded on poly-L-lysine-coated 6-
well plates or 100 mm dishes in normal medium for 24 h and then shifted to low serum medium (1% HS and 0.5% FBS) for 24 h prior to exposure to
indicated agents. (A) Cells were treated with vehicle (0.1% DMSO), NGF (50 ng/ml; 0.38 nM) and 5-OH-HxMF (10 and 20 mM) for 24 h, respectively.
Cellular RNA was then prepared and GAP-43 mRNA level was detected by RT-Q-PCR as described in Materials and Methods. Data represent the mean
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48 h to analyze the percentage of neurite bearing cells. As shown
in Figure 7D, K252a significantly inhibited NGF- but not 5-OH-
HxMF-induced neurite outgrowth in PC12 cells. In addition, we
also found that 5-OH-HxMF represented additive effect on NGF-
induced neurite outgrowth. These data suggest that 5-OH-HxMF
induces neurite outgrowth by activating a cAMP/PKA-dependent
and TrkA-independent signaling pathway coupling with CRE
mediated gene transcription.
We further investigated whether the other PKA-independent
pathways, such as ERK, PI3-K/Akt, CaMKII, and PKC, also
contribute to 5-OH-HxMF-mediated neurite outgrowth in PC12
cells. Figure S3 shows that 5-OH-HxMF-mediated neurite
outgrowth was partly reduced by BIM but not by LY294002,
KN-62 (CaMKII) or U0126, which could completely abolish basal
and 5-OH-HxMF-induced ERK phosphorylation (Figure S4).
These results suggest that PKC pathway, but not ERK, PI3K/
AKT, or CaMKII, may be associated with the CRE-independent
signaling, which also responsible in part for 5-OH-HxMF-
mediated neurite outgrowth.
Discussion
Therapeutic strategy to stimulate neuronal cell events including
proliferation, migration, differentiation, neurite outgrowth, and
synatogenesis are needed for several neurodegenerative disorders.
Small molecules, such as dietary flavonoids, may work as
therapeutic agents that possessed the high neurotrophic potency
and involved in numerous effects within the brain [44].
Traditionally, the neuroprotective effects of flavonoids have been
attributed to their ability to exert antioxidant actions [45], through
their ability to scavenge reactive species, or through their possible
influences on intracellular redox status [46]. Recently, it becomes
evident that flavonoids are able to stimulate neuronal regeneration
and induce neurogenesis via their interactions with critical
neuronal intracellular signaling pathways pivotal in controlling
Figure 4. Effects of 5-OH-HxMF and nobiletin on the phosphorylation of CREB protein in PC12 cells. PC12 cells were seeded on poly-L-
lysine-coated 100 mm dishes in normal medium for 24 h and then shifted to low serum medium (1% HS and 0.5% FBS) for 24 h prior to exposure to
indicated agents. Cells were treated with vehicle (0.1% DMSO), 5-OH-HxMF or nobiletin (20 mM) for 0 min, 30 min, 60 min or 120 min. Phosphor-CREB
(p-CREB) and CREB proteins were analyzed by Western blotting as described in Materials and Methods. The immunoblot experiments were replicated
at least three times and a representative blot was shown. Normalized intensity of p-CREB versus CREB is presented as the mean 6 SD of three
independent experiments. **p,0.01 represent significant differences compared with 0 min group.
doi:10.1371/journal.pone.0028280.g004
6 SD of three independent experiments. (B) Cells were treated with vehicle (0.1% DMSO), NGF (50 ng/ml; 0.38 nM) and 5-OH-HxMF (10 and 20 mM)
for 24 h. GAP-43 protein expression was detected by Western blotting as described in Materials and Methods. The immunoblot experiments were
replicated three times and a representative blot was shown. Normalized intensity of GAP-43 versus b-actin is presented as the mean 6 SD of three
independent experiments. *p,0.05 and **p,0.01 represent significant differences compared with vehicle-treated cells.
doi:10.1371/journal.pone.0028280.g003
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e28280Figure 5. Effects of 5-OH-HxMF, nobiletin, and inhibitor KG-501 on CRE-dependent gene transcription and neurite outgrowth in
PC12 cells. (A) PC12 cells were transfected with a CRE-mediated luciferase reporter construct and Renilla luciferase control plasmid for 24 h. After
transfection, PC12 cells were treated with vehicle (0.1% DMSO), 5-OH-HxMF (20 mM), or nobiletin (20 mM) for 8 h. For treatment of cells with inhibitor,
the transfected cells were pre-incubated with KG-501 (10 mM) for 30 min, then exposure of cells with vehicle, 5-OH-HxMF, or nobiletin for additional
8 h. Cells were harvested and luciferase activities were determined as described in Materials and Methods. The intensity of the luciferase reactions
measured in the lysates of the transfectants was normalized to their Renilla luciferase control activity. (B) PC12 cells were cultured on poly-L-lysine-
coated 6-well plates in low serum medium and treated with vehicle (0.1% DMSO) and 5-OH-HxMF (20 mM) for indicated period. Cellular RNA was then
prepared and c-fos mRNA level was detected by RT-Q-PCR as described in Materials and Methods. Data represent the mean 6 SD of three
independent experiments. (C) PC12 cells were seeded on poly-L-lysine-coated 6-well plates in normal medium for 24 h and then shifted to low serum
medium (1% HS and 0.5% FBS) for 24 h prior to exposure to vehicle (0.1% DMSO), 5-OH-HxMF (20 mM) or nobiletin (20 mM) for additional 48 h. For
treatment of cells with inhibitor, adherent cells were pre-incubated with KG-501 (10 mM) for 30 min and then exposure to indicated agents for
additional 48 h. Neurite bearing cells were analyzed as described in Materials and Methods. Data represent the mean 6 SD from three independent
experiments. (D) The maximal neurite length for each of the differentiated cells was analyzed and the average neurite length was calculated as
described in Materials and Methods. Data represent the mean 6 SD from three independent experiments. *p,0.05 and **p,0.01 represent
significant differences compared with vehicle-treated cells. #p,0.05 and ##p,0.01 represent significant differences compared with respective KG-
501-untreated group.
doi:10.1371/journal.pone.0028280.g005
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e28280neuronal survival and differentiation [47–49]. 5-Hydroxy-
3,6,7,8,39,49- hexamethoxyflavone (5-OH-HxMF) is one of the
most abundant hydroxylated PMFs in the sweet orange (C. sinensis
L.) peel oil [23]. Its known biological functions are limited to anti-
inflammatory and anti-cancer activities. For example, it exhibited
much stronger inhibitory effects on the growth of the colon cancer
cells than its permethoxylated counterpart, 3,5,6,7,8,39,49-hepta-
methoxylflavone [50]; it also induced HL-60 apoptosis [51,52] and
inhibited TPA-induced skin inflammation and tumor promotion
[53]. The major findings of this study are that 5-OH-HxMF, can
induce PC12 neurite outgrowth accompanied with the expression
of neuronal protein GAP-43. In addition, it was demonstrated that
5-OH-HxMF induced neurite outgrowth mainly via increases of
intracellular cAMP levels and PKA activity, which further
enhanced CREB phosphorylation and CRE dependent transcrip-
tion in PC12 cells (Figure 8).
In PC12 cells, neurite outgrowth can be stimulated by diverse
growth factors activating corresponding receptors: NGF, BDGF,
fibroblast growth factor (FGF), and epidermal growth factor (EGF)
accompanied by more than a 10-fold increase of GAP-43 and its
mRNA levels [35,54,55]. GAP-43 is one of the abundant nerve
ending proteins with the function of taking an incoming signal and
transducing it to the effectors and is therefore regarded as ‘‘signal’’
protein’’. It plays a critical role to regulate nerve sprouting and the
actin cytoskeleton [56]. In this research, we found that 5-OH-
HxMF and NGF stimulated neurite outgrowth with significantly
higher expression of GAP-43 mRNA and protein after 24 h
incubation.
It has been suggested that phosphorylation and dephosphory-
lation of CREB control its ability to regulate transcription which is
associated with neuronal function such as synapse re-modeling,
increases in neuronal spine density and synaptic plasticity [49]. In
this research, we clearly detected 5-OH-HxMF treatment induced
CREB phosphorylation, CRE-dependent transcription activity
and CREB target gene c-fos mRNA expression in PC12 cells.
Addition of CREB:CBP antagonist, KG501, suppressed 5-OH-
HxMF-induced luciferase activity in pCRE-Luc transfected PC12
cells and neurite outgrowth. Our findings indicate the close
correlation between CREB activation and the neuritogenesis in 5-
OH-HxMF-treated PC12 cells. Previously, Nagase et al. com-
pared the neurotrophic potencies of six citrus flavonoids, namely
nobiletin, 5-demethylnobiletin, tangeretin, sinensetin, 6-de-
methoxytangeretin and 6-demethoxynobiletin, in PC12D cells, a
derivative of the PC12 cell line which extends neurites very rapidly
in response to NGF, even when RNA synthesis is blocked. They
found that among the test compounds, nobiletin most potently
enhanced CREB phosphorylation, CRE-dependent transcription
and neurite outgrowth [28]. Herein, we found that 5-OH-HxMF
exhibited similar stimulatory activity as nobiletin for neurite
outgrowth and CREB phosphorylation. It is known that NGF-
responsive CREB activation also involved in the neuronal survival
and neuroprotection. Thus, we further examined the neuropro-
tective effect of 5-OH-HxMF and nobiletin against serum
deprivation-induced cell death. We found that nobiletin but not
5-OH-HxMF significantly increased the cell viability in serum free
cultured PC12 cells (data not shown). This result implies that 5-
OH-HxMF induced CREB activation through PKA involved in
neuritogenic action, but may be not play a vital role in the
cytoprotective effect against serum deprivation induced cell
apoptosis.
The activation of various signaling pathways, including cAMP-
dependent protein kinase A (PKA), PI3 k/Akt, protein kinase C
(PKC), calcium-calmodulin kinase II/IV (CaMKII/IV) and ERK
have been linked with the control of de novo protein synthesis in
the context of LTP (long term, synaptic plasticity and memory)
and converge to signal to CREB [14]. In this study, we found that
the adenylate cyclase inhibitor SQ22536 and the PKA inhibitor
H-89 significantly blocked the potentiation of 5-OH-HxMF-
induced neurite outgrowth, CRE transcription activity and CREB
phosphorylation. Moreover, we found that the MEK inhibitor
U0126, the PKC inhibitor BIM, the PI3K inhibitor LY294002
and the CaMKII inhibitor KN-62 did not significantly change 5-
OH-HxMF-induced CRE transcription activity. Additionally, we
found that 5-OH-HxMF induced the accumulation of intracellular
cAMP and PKA activity. The role how 5-OH-HxMF affects the
intracellular cAMP level remains unclear. Whether it is through
activation of adenylate cylase activity alone or in combination with
inhibition of phosphodiesterases (PDEs), which catalyze the
hydrolysis of cAMP and thereby increase intracellular cAMP
concentration to activate PKA, is an open question.
Cross talk has been found existing between cAMP/PKA and
ERK signaling pathways in PC12 cells [57]. It has been found that
nobiletin induces neurite outgrowth by activating a cAMP/PKA/
MEK/Erk/MAP kinase-dependent and TrkA-independent sig-
naling pathway coupling with CRE mediated gene transcription in
PC12 D cells [27]. The metabolite of nobiletin, 49-demethylno-
biletin was shown to stimulate the phosphorylation of ERK and
CREB and enhances CRE-mediated transcription by activating a
PKA/MEK/ERK pathway in cultured hippocampal neurons and
rescues learning impairment associated with NMDA receptor
antagonism [33]. In this study, we found that 5-OH-HxMF
increased the cellular levels of cAMP and PKA activity. Addition
of SQ22536, a adenylate cyclase inhibitor; and H-89, a PKA
inhibitor, significantly blocked the potentiation of 5-OH-HxMF-
induced neurite outgrowth, CREB phosphorylation and CRE
transcription activity. On the other hand, K252a, a TrkA
antagonist, did not affect 5-OH-HxMF-induced neurite out-
growth. While cells co-treated with NGF and 5-OH-HxMF
showed additive effect on neurite outgrowth. Our findings indicate
5-OH-HxMF induced PC12 cell neurite outgrowth through
cAMP/PKA/CREB pathway which is not associated with TrKA
activation.
In this study, we found that while PC12 cells treated with
inhibitor H-89 only partly reversed 5-OH-HxMF-induced neurite
Figure 6. Effects of the molecular inhibitors on the 5-OH-HxMF -mediated CREB activation. (A) PC12 cells were transfected with a CRE-
mediated luciferase reporter construct and Renilla luciferase control plasmid for 24 h. Following transfection, cells were pre-treated for 30 min with
inhibitors 10 mM U0126, 2.5 mM BIM, 20 mM LY294002, 10 mM KN-62, 500 mM SQ22536, 10 mM H-89 or vehicle (0.1% DMSO), followed by exposure to
5-OH-HxMF (20 mM) for 8 h. Forskolin (2 mM)-treated transfected cells as a positive control for CRE-luciferase reporter assay. The intensity of the
luciferase reactions measured in the lysates of the transfectants was normalized to their Renilla luciferase control activity. (B) PC12 cells were seeded
on poly-L-lysine-coated 100 mm dishes in normal medium for 24 h and then shifted to low serum medium (1% HS and 0.5% FBS) for further 24 h
culture. Cells were treated with inhibitor SQ22536 or H-89 for 30 min prior to exposure of vehicle (0.1% DMSO) or 5-OH-HxMF (20 mM) for 60 min.
Phosphor-CREB (p-CREB) and CREB were analyzed by Western blotting as described in Materials and Methods. The immunoblot experiments were
replicated at least three times and a representative blot was shown. Normalized intensity of p-CREB versus CREB is presented as the mean 6 SD of
three independent experiments. ** p,0.01 represents significant differences compared with vehicle. ## p,0.01 represents significant differences
compared with respective inhibitors-untreated group.
doi:10.1371/journal.pone.0028280.g006
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by KG-501 almost completely blocked the induction (Figure 5C).
Thus, a PKA-independent but CRE-dependent pathway may be
involved in 5-OH-HxMF-mediated neurite outgrowth. We next
examined the role of PKA-independent pathways in 5-OH-
HxMF-induced neurite outgrowth by specific kinase inhibitors.
Inhibition of PKC, but not MEK1/2, PI3-K/Akt, or CaMKII,
reduced the neurite outgrowth. PKC inhibitor modestly decreased
the percentage of 5-OH-HxMF-induced neurite outgrowth by
approximately 10%. However, inhibition of PKC did not
significantly affect CRE-mediated transcription activity
(Figure 6A). This finding indicates PKC pathway might be
partly involved in the 5-OH-HxMF-mediated neuritogenic action.
It has been reported that certain cAMP-dependent activities
were not inhibited by PKA inhibitor [58]. In this study, we found
that SQ22536 was more effective than H-89 at reducing 5-OH-
HxMF-induced neurite outgrowth. This result implies that a
cAMP-mediated but PKA-independent pathway may also partial-
ly contribute to the 5-OH-HxMF-mediated CREB activation and
neuritogenic action. Moreover, our data showed that 5-OH-
HxMF could transiently activate ERK which could be abolished
by U0126, an ERK phosphorylation inhibitor. However, 5-OH-
HxMF-induced CREB activation or neurite outgrowth was not
significantly affected by U0126. Therefore, there is no crosstalk
between ERK activation and 5-OH-HxMF-induced cAMP/PKA
pathway, CREB activation, or neuronal differentiation. Taken
together, these findings suggest that cAMP/PKA-dependent, but
not TrkA- or ERK-dependent, signaling pathway coupling with
CRE mediated gene transcription is involved in the mechanisms of
5-OH-HxMF-induced neurite outgrowth.
Materials and Methods
Chemicals
5-Hydroxy-3,6,7,8,39,49-hexamethoxyflavone and nobiletin
were purified as described before [23]. Poly-L-lysine, dimethyl
sulfoxide (DMSO), KN-62 [1-[N,O-bis(5-isoquinolinesulfonyl)-N-
methyl-L-tyrosyl]-4- phenylpiperazine], H-89 [N-[2-((p-Bromocin-
namyl)amino)ethyl]-5-isoquinolinesulfonamide], 2-naphthol AS-E
phosphate (KG-501), forskolin as well as other chemicals were
purchased from Sigma-Aldrich Co. (St. Louis, MO) unless
otherwise indicated. LY294200 [2-(4- morpholinyl)-8-phenyl-4H
-1-benzopyran-4-one], a PI3-K inhibitor, and U0126 [1,4-
diamino-2,3-dicyano-1,4- bis (2-aminophenylthio)butadiene], a
selective and potent inhibitor of MEK activity and activation of
ERK1/2, were purchased from Promega (Madison, WI, USA).
Bisindolylmaleimide I, a protein kinase C inhibitor, was purchase
from Cayman chemical (Ann Arbor, MI, USA). SQ22536 [9-
(Tetrehydro-2-furyl) adenine], a cell-permeable adenylate cyclase
inhibitor, and TrkA antagonist K252a were purchased from Enzo
Life sciences (Ann Arbor, MI, USA). The mouse 7S nerve growth
factor (NGF) was purchased from Millipore (Billerica, MA, USA).
Cell culture
PC12 cell, the rat adrenal pheochromocytoma cell line, was
obtained from Bioresource Collection and Research Center
(Hsinchu, Taiwan) and maintained in complete medium which
contains RPMI-1640 (Sigma-Aldrich), 2 mM glutamine, 1.5 g/L
sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES and 1 mM
sodium pyruvate, supplemented with 10% heat-inactivated horse
serum (HS) (Invitrogen, Carlsbad, CA, USA) and 5% fetal bovine
serum (FBS)(Biological Industries, Kibbutz Haemek, Israel) in 5%
CO2 incubator at 37uC.
Analysis of PC12 cell numbers by MTT assay
The survival cell numbers were measured by the mitochondrial-
dependent reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide (MTT) to purple formazan. Briefly, PC12
cells were incubated with MTT solution (1 mg/ml final concen-
tration) for 4 h at 37uC followed by centrifugation at 8,0006g for
4 min. The medium was carefully removed by aspiration, then the
formazan crystals were dissolved in dimethyl sulfoxide (DMSO).
Figure 7. The involvement of cAMP production and protein kinase A (PKA) activation in 5-OH-HxMF-induced neruite outgrowth.
PC12 cells were seeded on poly-L-lysine-coated 6-well and then shifted to low serum medium (1% HS and 0.5% FBS) for further 24 h culture. (A) Cells
were then incubated with 5-OH-HxMF (20 mM) for indicated period and cAMP level was determined by using enzyme immunoassay kit as described
in Materials and Methods. (B) Cells were then incubated with 5-OH-HxMF (20 mM) for indicated period and PKA activity was detected using ELISA kit
as described in Materials and Methods. Data represent the mean 6 SD of three independent experiments. *p,0.05 and ** p,0.01 represents
significant differences compared with 0 min group. (C) Cells were then treated for 30 min with inhibitors 500 mM SQ22536 (adenylate cyclase), 10 mM
H-89 (PKA) or vehicle (0.1% DMSO), prior to exposure to 5-OH-HxMF (20 mM) for 48 h. Percentage of neurite bearing cells and maximal neurite length
for each of the differentiated cells was analyzed as described in Materials and Methods. (D) Cells were then treated for 30 min with TrkA antagonist
K252a (100 nM) prior to exposure to NGF (100 ng/ml; 0.76 nM) or 5-OH-HxMF (20 mM) for 48 h. The neurite bearing cells were analyzed as described
in Materials and Methods. Data represent the mean 6 SD from three independent experiments. ** p,0.01 represents significant differences
compared with vehicle-treated cells. ## p,0.01 represents significant differences compared with respective inhibitor-untreated group.
doi:10.1371/journal.pone.0028280.g007
Figure 8. Hypothetic mechanism of 5-OH-HxMF in promoting
neurite outgrowth in PC12 cells. 5-OH-HxMF could induce neurite
outgrowth associated with expression of neuronal differentiation
marker (Figure 2 and 3). 5-OH-HxMF induced neurite outgrowth
through stimulating CREB phosphorylation and activation of CRE-
dependent transcription activity (Figure 4 and 5). 5-OH-HxMF stimulat-
ed CREB phosphorylation and neurite outgrowth mainly through
activation of cAMP-dependent protein kinase A (PKA) and TrkA-
independent pathway in PC12 cells (Figure 6 and 7). Another PKA-
independent pathway, protein kinase C (PKC), was also partly involved
in the 5-OH-HxMF-induced neurite outgrowth. In addition, the PKA-
independent but CRE-dependent pathways may also partially contrib-
ute to the 5-OH-HxMF-mediated neurite outgrowth. As a result, 5-OH-
HxMF promotes neurite outgrowth mainly through activation of cAMP/
PKA/CREB pathway in PC12 cells.
doi:10.1371/journal.pone.0028280.g008
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Analysis of neurite outgrowth of PC12 cells
Morphological analysis and quantification of neurite bearing
cells were carried out using phase-contrast microscope as
described previously [59,60]. Briefly, PC12 cells (3610
5/ml) were
seeded on poly-L-lysine-coated 6-well plates in the normal serum
medium for 24 h. The RPMI medium containing low serum (1%
HS and 0.5% FBS) was replaced prior to exposure to vehicle
(0.1% DMSO) or indicated reagents. After an additional 48 h of
incubation, neurite outgrowth of PC12 cell was observed under an
inverted microscope (Olympus IX71) using phase-contrast objec-
tives and photographed by the digital camera. At least 100 cells in
each of ten randomly separated fields were scored and the
proportion of cells with neurites greater than or equal to the length
of one cell body were scored positive for neurite outgrowth, and
expressed as a percentage of the total cell number in ten fields.
The neurite extension length was also measured for all identified
positive neurite-bearing cells in a field by tracing the longest length
of neurite per cell using Image J software (NIH Image software).
The value of neurite length (average maximal neurite length per
neurite-bearing cell in ten fields) was calculated and data from the
ten fields in each well was designated as one experiment.
Experiments were repeated at least three times on separate days
and data are expressed as mean 6SD.
For detection of neurite outgrowth by indirect immunofluores-
cence, PC12 cells were seeded on poly-L-lysine-coated coverslip in
the normal serum medium for 24 h, then the RPMI medium
containing low serum medium was replaced prior to exposure to
NGF. After an additional 48 h of incubation, PC12 cells were
fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS)
for 15 min, washed, permeabilized with 0.1% Triton X-100, and
soaked in blocking buffer (PBS containing 1% BSA) for 60 min at
room temperature. After blocking, immunostaining was conducted
by incubation with the primary anti-GAP-43 antibody (Millipore,
Billerica, MA, USA), washed, and incubated the secondary Alexa
Fluor 488-conjugated goat anti-mouse IgG antibody (Invitrogen,
Carlsbad, CA, USA) for 60 min. The cells were then washed four
times in PBS and incubated with 49,6- diamidino-2-phenylindole
(DAPI) solution for 2 min for nuclear staining. The coverslips were
again washed in PBS, drained, and mounted with Fluoromount G
(Andes import). The cells were viewed and photographed on the
inverted fluorescence microscope (Olympus IX71).
Reverse transcription quantitative PCR (RT-Q-PCR)
analysis of GAP-43 and c-fos
PC12 cells (1610
6/ml) were seeded on poly-L-lysine-coated 6-
well plates in normal medium for 24 h. The cells were then shifted
to low serum (1% HS and 0.5% FBS) as indicated for 24 h prior to
exposure to vehicle (0.1% DMSO) or indicated reagents for
indicated period. Total cellular RNA was prepared using Total
RNA mini Kit (Geneaid, Taipei, Taiwan). Reverse transcription of
2 mg RNA was performed using High Capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA, USA).
Quantitative real-time PCR was performed with 2 mL cDNA
obtained above in 25 mL containing 200 nM primers [GAP-43,
59-CTAAGGAAAGTGCCCGACAG-39 (forward) and 59-GC-
AGGAGAGACAGGGTTCAG-39 (reverse); b-actin, 59-CCTC-
TGAACCCTAAGGCCAA-39 (forward) and 59-AGCCTGG-
ATGGCTACGTACA-39 (reverse)[59]; c-fos, 59-TCTCCTGAA-
GAGGAAGAGAAACGG-39 (forward) and 59-TCTGCAACG-
CAGACTTCTCG-39 (reverse) [61]] and Maxima SYBR Green/
ROX qPCR Master Mix (Fermentas, Burlington, CA). Amplifi-
cation was conducted in an ABI Prism 7300 Real-Time PCR
System. PCR conditions were as follows: 94uC for 4 min, 40 cycles
at 94uC for 1 min, 58uC for 1 min, and 72uC for 1 min. The
DDCt method was used for data analysis of GAP-43 mRNA
expression estimated in triplicate samples and normalized to b-
actin expression levels.
Western blotting analysis of GAP-43, CREB, and ERK
proteins
PC12 cells (1610
6/ml) were seeded on poly-L-lysine-coated
100 mm dishes in normal serum medium for 24 h, then shifted to
low serum (1% HS and 0.5% FBS) as indicated for 24 h prior to
exposure to vehicle (0.1% DMSO) or indicated reagent for indicated
periods. Cells werewashed with PBS, scraped inice coldRIPA buffer
(Thermo Fisher Scientific, Inc., Rockford, IL) and incubated on ice
for 15 min. The cellular debris was removed by centrifugation
(8,0006g for 15 min) at 4uC and the cell lysate was carefully
transferred to the microcentrifuge tube. The protein concentration
was measured by the Bradford method (Bio-Rad Laboratories,
Hercules, CA, USA) using bovine serum albumin as a standard.
Cell lysate (30 mg) was separated on 10% SDS-PAGE and
transferred onto PVDF membrane (PerkinElmer, Boston, MA, USA)
at 25 volt overnight at 4uC. The membranes were blocked at 4uCi n
PBST blocking buffer (1% non-fat dried milk in PBS containing 0.1%
Tween-20) for 8 h. Blots were incubated with the appropriate
antibodies overnight at 4uC: anti-GAP-43 (1:1000) (Millipore, Billerica,
MA, USA), anti-b-actin (1:8000) (Sigma-Aldrich), anti-phospho-
CREB(Ser-133) (1:1000), anti-CREB (1:1000), anti-ERK1/2 (1:1000)
and anti-phospho-ERK1/2 (1:1000) (Cell Signaling Technology, Inc.).
After three washes with PBST, the blots were incubated with
appropriate horseradish peroxidase-conjugated secondary antibodies
(1:10,000) for 1 h. The blots were washed again and detected the
proteins of interest by Western Lightning
TM Chemiluminescence
Reagent Plus (PerkinElmer, Boston, MA,U S A )a c c o r d i n gt ot h e
manufacturer’s instructions, and then the chemiluminescence signal
was visualized with X-ray film.
Reporter gene assay of cyclic AMP response element
(CRE)-mediated transcription activity
PC12 cells (2610
5/well) were seeded on poly-L-lysine-coated
24-wells plate in DMEM containing 10% HS and 5% FBS
medium for 24 h. For transient transfection, cells were cotrans-
fected with the pCRE-Luc Cis-reporter plasmid (Stratagene, La
Jolla, CA, USA) and Renilla luciferase vector (Promega) using
Lipofectamine 2000 (Invitrogen). Twenty-four hours after trans-
fection, cells were treated with vehicle (0.1% DMSO), 5-OH-
HxMF (20 mM), or nobiletin for 8 h and harvested by using
Passive Lysis Buffer (Promega). For treatment of PC12 cells with
inhibitors, the transfected cells were pre-incubated with different
inhibitors for 30 min, then treated with indicated agents for 8 h
before harvesting the cell lysates. Luciferase activities were
determined by the Dual-Luciferase Reporter Assay System Kit
(Promega) according to the manufacturer’s instructions. The
intensity of the luciferase reactions measured in the lysates of the
transfectants was normalized to their Renilla luciferase activity,
which was used as an internal control.
Analysis of cyclic AMP (cAMP) levels
PC12 cells (1610
6/ml) were seeded on poly-L-lysine-coated 6-
well plates in normal medium for 24 h. The cells were then shifted
to low serum (1% HS and 0.5% FBS) as indicated for 24 h prior to
exposure to 5-OH-HxMF compound for indicated periods. Cells
were treated with 0.1 M HCl after removing the culture media
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centrifuged at room temperate and the supernatant was used
directly in the assay. The intracellular cyclic AMP level was
measured by the Direct Cyclic AMP Enzyme Immunoassay Kit
(Enzo Life Sciences) according to the manufacturer’s instructions.
Analysis of protein kinase A (PKA) activity
A nonradioactive protein kinase A (PKA) activity assay kit (Enzo
Life Sciences) was used to measure PKA activity in the samples.
PC12 cells (1610
6/ml) were seeded on poly-L-lysine-coated
100 mm dishes in normal serum medium for 24 h, then shifted
to low serum (1% HS and 0.5% FBS) as indicated for 24 h prior to
exposure to 5-OH-HxMF compound for indicated periods.
Cellular proteins were collected using lysis buffer according to
the manufacturer’s instruction. PKA substrate microtiter plate,
which was pre-coated with PKA substrate, was soaked with kinase
assay dilution buffer for 10 min at room temperature. 30 mL of cell
lysates (100 ng) or PKA standard (10 ng) were then added,
followed by the addition of ATP to initiate the reaction. After
incubation at 30uC for 90 min, the reaction mixture was removed
from the plate, and phosphospecific substrate antibody was added
to each well and incubated at room temperature for 60 min. The
liquid was aspirated and wells were repeatedly washed. HRP-
conjugated secondary anti-rabbit IgG was then added to each well
and incubated for another 30 min at room temperature. The wash
was repeated after incubation and TMB substrate solution was
added to each well. Stop solution was added after 30–60 min and
the 96-well plate was read at 450 nm in a microplate reader.
Statistical Analysis
All experiments were repeated at least three times. The results
were analyzed by Student’s unpaired t-test and a p value of ,0.05
was taken to be significant.
Supporting Information
Figure S1 Effects of 5-OH-HxMF and nobiletin on the
cell viability of PC12 cells. PC12 cells(1610
5/well)were seeded
on 24-well plates in normal serum (10% HS and 5% FBS), low serum
medium (1% HS and 0.5% FBS) and exposed to vehicle (0.1%
DMSO), NGF (as a positive control), 5-OH-HxMF or nobiletin (0–
50 mM) for 48 h. The relative cell counts were determined by MTT
assay as described in the Materials and Methods and expressed as
percentage of control group, which represents the cell counts prior to
medium change. Data represent the mean 6 SD from three
independent experiments. *p,0.05 and **p,0.01 represent signifi-
cant differences compared with control group cells.
(TIF)
Figure S2 Analysis of neurite outgrowth in PC12 cells.
PC12 cells were seeded on poly-L-lysine-coated 6-well plates in low
serum medium for 24 h prior to exposure to vehicle (0.1% DMSO)
or NGF for additional 48 h. Cell morphology was observed using
phase-contrast microscopy and photographed by the digital camera.
(A) Phase contrast micrographs of PC12 cells. Arrowheads indicate
the neurite bearing cells in vehicle- or NGF (100 ng/ml)-treated
groups. Scale bar, 100 mm. (B) PC12 cells were treated with NGF
(indicated concentration) for 48 h or 96 h. Neurite bearing cells were
analyzed as described in Materials and Methods. Data represent the
mean 6 SD from three independent experiments. *p,0.05 and
**p,0.01 represents significant differences compared with those of
the vehicle-treated cells. (C) PC12 cells were seeded on poly-L-lysine-
coated coverslip and cultured in the low serum medium for NGF
(100 ng/ml) treatment for 48 h. Indirect immunofluorescence assay
for detecting GAP-43 protein as described in Materials and Methods.
GAP-43 protein was detected by immunofluorescence microscope
(green). DAPI stains nuclei (blue). Arrowheads indicate the neurite
bearing cells. Scale bar; 100 mm.
(TIF)
Figure S3 Effects of protein kinase inhibitors on the 5-
OH-HxMF-induced neurite outgrowth. PC12 cells were
seeded on poly-L-lysine-coated 6-well plates in normal serum medium
for 24 h. Cells were then shifted to low serum medium (1% HS and
0.5% FBS) for 24 h and then were pre-treated for 30 min with
inhibitors 10 mM U0126 (MEK1/2), 2.5 mMB I M( P K C ) ,4 0mM
LY294002 (PI3-K/Akt), and 10 mM KN-62 (CaMKII), respectively,
followed by exposure to 5-OH-HxMF (20 mM) for 48 h. Neurite
bearing cells were analyzed as described in Materials and Methods.
Data represent the mean 6 SD from three independent experiments.
** p,0.01 represents significant differences compared with vehicle-
treated cells. ## p,0.01 represents significant differences compared
with respective inhibitor-untreated group.
(TIF)
Figure S4 Effects of 5-OH-HxMF on the phosphoryla-
tion of ERK proteins. PC12 cells were seeded on poly-L-lysine-
coated 100 mm dishes in normal medium for 24 h and then
shifted to low serum medium (1% HS and 0.5% FBS) for 24 h
prior to exposure to indicated agents. Cells were treated with 5-
OH-HxMF (20 mM) for 0 min, 15 min, and 30 min. Phosphor-
ERK1/2 (p-ERK1/2) and total ERK1/2 proteins were analyzed
by Western blotting as described in Materials and Methods. The
immunoblot experiments were replicated at least three times and a
representative blot was shown.
(TIF)
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